In both the overall cohort and the Aβ‐positive subgroup, higher p‐tau217 levels were significantly associated with cortical thinning in both hemispheres, reinforcing its role as a key marker of tau pathology and neuronal damage in individuals with AD.43, 44. Here, MAPT is linked to Alzheimer disease.